Evidence map›Paper›PMID 28544662›Full record

ArticleStem cells translational medicine2017

Tracheal Replacement Therapy with a Stem Cell-Seeded Graft: Lessons from Compassionate Use Application of a GMP-Compliant Tissue-Engineered Medicine.

Martin J Elliott, Colin R Butler, Aikaterini Varanou-Jenkins, Leanne Partington, Carla Carvalho, Edward Samuel, Claire Crowley, Peggy Lange, Nicholas J Hamilton, Robert E Hynds and 13 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Stem cells translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Engineered Anti-Senescence Trachea With Post-Transplanted Regenerative Homeostasis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Tissue-Engineered Tracheal Reconstruction.Biomimetics (Basel, Switzerland) · 2025
    Review
  14. Article
  15. A 28-Year-Old Man with Stridor and Dyspnea.Journal of clinical medicine · 2025
    Article
  16. Article
  17. Tracheal Replacement: A Scoping Review.Surgery journal (New York, N.Y.) · 2024
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 1 country.

Martin J ElliottTracheal Team, Great Ormond Street Children's Hospital, London, United Kingdom.
Colin R ButlerTracheal Team, Great Ormond Street Children's Hospital, London, United Kingdom.ORCID 0000-0003-4192-0519
Aikaterini Varanou-JenkinsLungs for Living Research Centre, UCL Respiratory, University College London, United Kingdom.
Leanne PartingtonCentre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital & UCL, London, United Kingdom.
Carla CarvalhoCentre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital & UCL, London, United Kingdom.
Edward SamuelCentre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital & UCL, London, United Kingdom.
Claire CrowleyDepartment of Paediatric Surgery, Great Ormond Street Children's Hospital and UCL Institute of Child Health, London, United Kingdom.
Peggy LangeDepartment of Surgical Research, Northwick Park Institute of Medical Research, Northwick Park Hospital, Harrow, United Kingdom.
Nicholas J HamiltonLungs for Living Research Centre, UCL Respiratory, University College London, United Kingdom.
Robert E HyndsLungs for Living Research Centre, UCL Respiratory, University College London, United Kingdom.ORCID 0000-0002-2170-8791
Tahera AnsariDepartment of Surgical Research, Northwick Park Institute of Medical Research, Northwick Park Hospital, Harrow, United Kingdom.
Paul SibbonsDepartment of Surgical Research, Northwick Park Institute of Medical Research, Northwick Park Hospital, Harrow, United Kingdom.
Anja FierensTracheal Team, Great Ormond Street Children's Hospital, London, United Kingdom.
Claire McLarenDepartment of Interventional Radiology, Great Ormond Street Children's Hospital and UCL Institute of Child Health, London, United Kingdom.
Derek RoebuckDepartment of Interventional Radiology, Great Ormond Street Children's Hospital and UCL Institute of Child Health, London, United Kingdom.
Colin WallisDepartment of Respiratory Medicine, Great Ormond Street Children's Hospital and UCL Institute of Child Health, London, United Kingdom.
Nagarajan MuthialuTracheal Team, Great Ormond Street Children's Hospital, London, United Kingdom.
Richard HewittTracheal Team, Great Ormond Street Children's Hospital, London, United Kingdom.
David CrabbeDepartment of Paediatric Surgery, Leeds General Infirmary, Leeds, United Kingdom.
Sam M JanesLungs for Living Research Centre, UCL Respiratory, University College London, United Kingdom.ORCID 0000-0002-6634-5939
Paolo De CoppiDepartment of Paediatric Surgery, Great Ormond Street Children's Hospital and UCL Institute of Child Health, London, United Kingdom.ORCID 0000-0002-1659-0207
Mark W LowdellCentre for Cell, Gene & Tissue Therapeutics, Royal Free Hospital & UCL, London, United Kingdom.
Martin A BirchallUCL Ear Institute and The Royal National Throat Nose and Ear Hospital, London, United Kingdom.
University College London · GBGreat Ormond Street Hospital · GBNorthwick Park Institute for Medical Research · GBLeeds General Infirmary · GBLiving Streets · GBNorthwick Park Hospital · GBThe Royal Free Hospital · GB

Funding

Department of Health RP_2014-04-046Medical Research Council G1001539Medical Research Council MR/L002000/1Wellcome Trust WT091730AIA
6 · The paper itself

Abstract

Tracheal replacement for the treatment of end-stage airway disease remains an elusive goal. The use of tissue-engineered tracheae in compassionate use cases suggests that such an approach is a viable option. Here, a stem cell-seeded, decellularized tissue-engineered tracheal graft was used on a compassionate basis for a girl with critical tracheal stenosis after conventional reconstructive techniques failed. The graft represents the first cell-seeded tracheal graft manufactured to full good manufacturing practice (GMP) standards. We report important preclinical and clinical data from the case, which ended in the death of the recipient. Early results were encouraging, but an acute event, hypothesized to be an intrathoracic bleed, caused sudden airway obstruction 3 weeks post-transplantation, resulting in her death. We detail the clinical events and identify areas of priority to improve future grafts. In particular, we advocate the use of stents during the first few months post-implantation. The negative outcome of this case highlights the inherent difficulties in clinical translation where preclinical in vivo models cannot replicate complex clinical scenarios that are encountered. The practical difficulties in delivering GMP grafts underscore the need to refine protocols for phase I clinical trials. Stem Cells Translational Medicine 2017;6:1458-1464.

Indexed as

AdolescentBioartificial OrgansCells, CulturedFemaleHumansOrgan TransplantationPostoperative ComplicationsStem CellsTissue EngineeringTissue ScaffoldsTracheaTracheal StenosisBioartificial organsBioengineeringRegenerative medicineTissue engineeringTissue scaffoldsTrachea

Identifiers

PMID28544662
PMCPMC5689750
OpenAlexW2618065424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.